Tech Company Financing Transactions
KellBenx Funding Round
On 7/30/2013, KellBenx secured $10 million in Series C investment from private investors.
Transaction Overview
Company Name
Announced On
7/30/2013
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series C
Investors
Proceeds Purpose
The financing will be used to accelerate clinical trials for its technology.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3500 Sunrise Hwy. Building 200 111
Great River, NY 11739
USA
Great River, NY 11739
USA
Phone
Website
Email Address
Overview
KellBenx, Inc. is a privately-held biotechnology company based in New York City. KellBenx is developing high value, innovative tests that leverage the ability to extract clinically relevant information from blood.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Hassan Bennani
Chief Medical Officer
Jonathan Herman
Chief Scientific Officer
Javad Khosravi
VP - R & D
Jeffrey Kazzaz
Browse more venture capital transactions:
Prev: 7/30/2013: Xtreme Power venture capital transaction
Next: 7/30/2013: ReelGenie venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs